A senior Thai physician urged men over 40 to undergo targeted screening — including annual FIT, colonoscopy every 10 years, or CT colonography every 5 years — for five silent cancers rather than wait for symptoms.
Thai men over 40 face rising risks from five aggressive cancers that often progress silently until advanced stages, a senior physician warned this week, urging targeted screening based on age and risk factors rather than waiting for symptoms, according to LINE TODAY.
He emphasized that while many men monitor blood pressure and blood sugar in their 40s and 50s, cancer surveillance is frequently neglected until disease becomes symptomatic—often too late for curative intent.
Top Five Cancers Threatening Thai Men
- Liver and bile duct, lung, colorectal, prostate, and oral cancers are the top five threats for Thai men, driven by viral hepatitis, smoking, diet, and aging.
- Screening saves lives: Ultrasound every six months for high-risk liver patients, low-dose CT for heavy smokers aged 50–80, and colonoscopy or stool tests starting at 45.
- PSA blood testing for prostate cancer requires a shared decision with a doctor starting at 50 (or 45 with family history); an elevated PSA does not equal cancer.
Viral Hepatitis Drives Liver Cancer
Hepatocellular carcinoma (HCC) and cholangiocarcinoma dominate male cancer mortality in Thailand. Chronic hepatitis B and C infection, cirrhosis, and liver fluke infection (Opisthorchis viverrini) from raw freshwater fish are the primary drivers. The World Health Organization estimates Thailand has one of the world’s highest cholangiocarcinoma burdens, particularly in the Northeast where raw fish dishes like koi pla are cultural staples.
He warned against waiting for elevated liver enzymes—by the time alanine aminotransferase (ALT) rises, tumors may already be advanced.
“People with cirrhosis or hepatitis B in certain risk groups should receive surveillance for liver cancer with ultrasound every 6 months according to their risk level. Do not wait for liver enzymes to rise first.”
Dr. Jedsada Bunyawongviroj, Deputy Director, Maharat Nakhon Ratchasima Hospital
Low-Dose CT Screening Targets Smokers
Lung cancer remains the leading cause of cancer death globally. He clarified that chest X-ray lacks sensitivity for early nodules and is not a screening tool.
Critically, he noted never-smokers also develop lung cancer—particularly adenocarcinoma driven by EGFR mutations prevalent in Asian populations—though no population-wide screening exists for this group.
Colorectal Screening Now Begins at 45
Colorectal cancer (CRC) incidence is rising in Thai men. Options include annual fecal immunochemical testing (FIT), colonoscopy every 10 years, or CT colonography every 5 years.
Global guidelines, including USPSTF and the American Cancer Society, now recommend average-risk screening initiation at age 45, down from 50, reflecting rising early-onset CRC. First-degree relatives with CRC warrant earlier initiation, typically at age 40 or 10 years before the youngest affected relative’s diagnosis.
Prostate Cancer: PSA Testing Requires Shared Decision-Making
Prostate cancer is the most common male cancer in many Western nations and rising in Thailand. Men with a father or brother diagnosed before 65 should consider baseline PSA at 45.
He stressed a critical nuance: PSA elevation occurs in benign prostatic hyperplasia (BPH) and prostatitis, not just malignancy. Overdiagnosis of indolent tumors remains a concern; magnetic resonance imaging (MRI) fusion biopsy now improves specificity over systematic biopsy.
Oral Cancer: The Betel Quid and Tobacco Synergy
Oral cavity cancer risk escalates with the triad of smoking, heavy alcohol use, and betel quid (Areca catechu) chewing—a Group 1 carcinogen per the International Agency for Research on Cancer (IARC).
No population screening program exists; opportunistic examination during dental visits is the primary detection route. HPV-related oropharyngeal cancer, rising globally, presents differently—often as a painless neck mass—and warrants separate clinical awareness.
| Cancer Type | Key Risk Factors | Screening Modality | Target Population |
|---|---|---|---|
| Liver / Bile Duct | Hepatitis B/C, Cirrhosis, Liver Fluke (Raw Fish) | Abdominal Ultrasound ± AFP | High-risk: Every 6 months |
| Lung | Smoking ≥20 Pack-Years, Age | Low-Dose CT (LDCT) | Age 50–80, Current/Former Smokers (quit <15 yrs) |
| Colorectal | Age, Family History, Diet, Obesity | Colonoscopy / FIT / CT Colonography | Age 45+ (Average Risk); Earlier if Family History |
| Prostate | Age, Family History, Ethnicity | PSA Blood Test (± MRI) | Age 50–69 (Shared Decision); 45 if High Risk |
| Oral Cavity | Tobacco, Alcohol, Betel Quid, HPV | Clinical Oral Exam | Opportunistic / High-Risk Surveillance |
Contraindications & When to Consult a Doctor
Screening carries harms: false positives drive invasive biopsies; overdiagnosis treats cancers that would never threaten life. LDCT is not recommended for adults with limited life expectancy or unwillingness to undergo curative surgery. Colonoscopy requires bowel preparation and sedation, posing perforation and bleeding risks (approximately 1 in 1,000 procedures).
Dr. Jedsada Bunyawongviroj, Deputy Director of Maharat Nakhon Ratchasima Hospital, previously addressed Sudden Unexplained Nocturnal Death Syndrome, known locally as “widow ghost” disease, explaining that medical science links these deaths to Brugada syndrome rather than folklore.
He also serves as Deputy Director of Primary Care Affairs at the hospital, where he has clarified that dizziness upon standing is often dismissed as standing up too quickly but may signal underlying conditions requiring investigation.
Seek immediate evaluation for: unexplained weight loss >5% in six months; persistent cough >3 weeks or hemoptysis; rectal bleeding or change in bowel habit >4 weeks; urinary obstruction, bone pain, or palpable prostate nodule; oral ulcer persisting >2 weeks with induration or fixation.
References
- U.S. Preventive Services Task Force. Lung Cancer: Screening (2021).
- American Association for the Study of Liver Diseases. HCC Surveillance Guidance (2018, Updated).
- World Health Organization / IARC. Betel Quid and Areca Nut Carcinogenicity (Group 1).
- American Cancer Society. Colorectal Cancer Screening Guidelines (2023 Update).
- National Comprehensive Cancer Network. Prostate Cancer Early Detection Guidelines (Version 2.2024).